Cmarik J L, Humphreys W G, Bruner K L, Lloyd R S, Tibbetts C, Guengerich F P
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
J Biol Chem. 1992 Apr 5;267(10):6672-9.
The major DNA adduct (greater than 95% total) resulting from the bioactivation of ethylene dibromide by conjugation with GSH is S-(2-(N7-guanyl)ethyl)GSH. The mutagenic potential of this adduct has been uncertain, however, because the observed mutagenicity might be caused by other adducts present at much lower levels, e.g. S-(2-N1-adenyl)ethyl)GSH. To assess the formation of other potential adducts, S-(2-(N3-deoxycytidyl)ethyl)GSH, S-(2-(O6-deoxyguanosyl)ethyl)GSH, and S-(2-(N2-deoxyguanosyl)ethyl)GSH were prepared and used as standards in the analysis of calf thymus DNA modified by treatment with [1,2-14C]ethylene dibromide and GSH in the presence of rat liver cytosol; only minor amounts (less than 0.2%) were found. A forward mutation assay in (repair-deficient) Salmonella typhimurium TA100 and sequence analysis were utilized to determine the type, site, and frequency of mutations in a portion of the lacZ gene resulting from in vitro modification of bacteriophage M13mp18 DNA with S-(2-chloroethyl)GSH, an analog of the ethylene dibromide-GSH conjugate. An adduct level of approximately 8 nmol (mg DNA)-1 resulted in a 10-fold increase in mutation frequency relative to the spontaneous level. The spectrum of spontaneous mutations was quite varied, but the spectrum of S-(2-chloroethyl)GSH-induced mutations consisted primarily of base substitutions of which G:C to A:T transitions accounted for 75% (70% of the total mutations). All available evidence implicates S-(2-(N7-guanyl)ethyl)GSH as the cause of these mutations inasmuch as the levels of the minor adducts are not consistent with the mutation frequency observed in this system. The sequence selectivity of alkylation was determined by treatment of end-labeled lac DNA fragments with S-(2-chloroethyl)GSH, cleavage of the DNA at adduct sites, and electrophoretic analysis. Comparison of the sequence selectivity with the mutation spectrum revealed no obligate relationship between the extent of adduct formation and the number of mutations which resulted at different sites. We suggest that the mechanism of mutagenesis involves DNA sequence-dependent alterations in the interaction of the polymerase with the (modified) template and incoming nucleotide.
二溴乙烷与谷胱甘肽(GSH)结合进行生物活化产生的主要DNA加合物(占总量的95%以上)是S-(2-(N7-鸟嘌呤基)乙基)谷胱甘肽。然而,这种加合物的致突变潜力一直不确定,因为观察到的致突变性可能是由其他含量低得多的加合物引起的,例如S-(2-N1-腺嘌呤基)乙基)谷胱甘肽。为了评估其他潜在加合物的形成情况,制备了S-(2-(N3-脱氧胞苷基)乙基)谷胱甘肽、S-(2-(O6-脱氧鸟苷基)乙基)谷胱甘肽和S-(2-(N2-脱氧鸟苷基)乙基)谷胱甘肽,并将其用作标准品,用于分析在大鼠肝细胞溶胶存在下用[1,2-14C]二溴乙烷和谷胱甘肽处理的小牛胸腺DNA;仅发现少量(小于0.2%)。利用(修复缺陷型)鼠伤寒沙门氏菌TA100中的正向突变试验和序列分析来确定用二溴乙烷-GSH共轭物的类似物S-(2-氯乙基)谷胱甘肽对噬菌体M13mp18 DNA进行体外修饰后,lacZ基因一部分中的突变类型、位点和频率。约8 nmol(mg DNA)-1的加合物水平导致突变频率相对于自发水平增加了10倍。自发突变的谱非常多样,但S-(2-氯乙基)谷胱甘肽诱导的突变谱主要由碱基替换组成,其中G:C到A:T的转换占75%(占总突变的70%)。所有现有证据都表明S-(2-(N7-鸟嘌呤基)乙基)谷胱甘肽是这些突变的原因,因为次要加合物的水平与该系统中观察到的突变频率不一致。通过用S-(2-氯乙基)谷胱甘肽处理末端标记的lac DNA片段、在加合物位点切割DNA以及进行电泳分析来确定烷基化的序列选择性。将序列选择性与突变谱进行比较,结果表明加合物形成的程度与不同位点产生的突变数量之间没有必然关系。我们认为,诱变机制涉及DNA序列依赖性地改变聚合酶与(修饰的)模板和进入核苷酸之间的相互作用。